Comparison of pregnancy outcome of euploid fetuses with increased nuchal translucency (NT) expressed in NT MoM or delta-NT

Ultrasound in Obstetrics and Gynecology

Volumn 23, Issue 5, 2004, Pages 477-481

  Maymon, R ^a,c   Tercanli, S ^b   Dreazen, E ^a   Sartorius, G ^b   Holzgreve, W ^b   Herman, A ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSITY WOMEN S HOSPITAL   (Switzerland)

^c ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

Delta NT; Euploid fetuses; Fetal abnormalities; Increased nuchal translucency; Multiple of the median; Pregnancy outcome

Indexed keywords

ARTICLE; DELTA NUCHAL TRANSLUCENCY THICKNESS; DEVELOPMENTAL DISORDER; EUPLOID FETUS; FETUS; FETUS DISEASE; FETUS ECHOGRAPHY; FETUS OUTCOME; FETUS RISK; GENETIC DISORDER; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; LOGISTIC REGRESSION ANALYSIS; NERVE CELL DIFFERENTIATION; NUCHAL TRANSLUCENCY THICKNESS IN MULTIPLE OF THE MEDIAN; PERINATAL PERIOD; POSTNATAL DEVELOPMENT; PREDICTION; PREGNANCY COMPLICATION; PREGNANCY DISORDER; PREGNANCY TERMINATION; PRENATAL SCREENING; PRIORITY JOURNAL; SPONTANEOUS ABORTION;

ABNORMALITIES; ABORTION, SPONTANEOUS; ABORTION, THERAPEUTIC; ANEUPLOIDY; CHI-SQUARE DISTRIBUTION; FEMALE; FETAL DISEASES; HUMANS; INCIDENCE; INFANT, NEWBORN; PREGNANCY; PREGNANCY OUTCOME; REFERENCE VALUES; REGRESSION ANALYSIS; ULTRASONOGRAPHY, PRENATAL;

EID: 2442624712     PISSN: 09607692     EISSN: None     Source Type: Journal    
DOI: 10.1002/uog.1060     Document Type: Article

References (25)

1. Pandya PP, Snijders RJM, Johnson SJ, de Lourdes Brizot MJ, Nicolaides KH. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Br J Obstet Gynaecol 1995; 102: 957-962.
2. Snijders RJM, Noble PL, Sebire NJ, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and nuchal translucency thickness at 10-14 weeks of gestation. Lancet 1998; 352: 343-346.
3. Taipale P, Hiilesmaa V, Salonen R, Ylostalo P. Increased nuchal translucency as a matter for fetal chromosomal defects. N Engl J Med 1997; 337: 1654-1658.
4. Hyett JA. Increased nuchal translucency in fetuses with a normal karyotype. Prenat Diagn 2002; 22: 864-868.
5. Souka AP, Krampl E, Bakalis S, Heath V, Nicolaides KH. Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester. Ultrasound Obstet Gynecol 2001; 18: 9-17.
6. Nicolaides KH, Azar G, Byrne D, Mansur N, Marks K. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 1992; 304: 867-869.
7. Yagel S, Imbar T, Valsky DV. Re: outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester. Ultrasound Obstet Gynecol 2002; 19: 417-421.
8. Maymon R, Jauniaux E, Cohen O, Dreazen E, Weinraub Z, Herman A. Pregnancy outcome and infant follow-up of fetuses with abnormally increased first trimester nuchal translucency. Hum Reprod 2000; 15: 2023-2027.
9. Michailidis GD, Economides DL. Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses. Ultrasound Obstet Gynecol 2001; 17: 102-105.
10. Herman A, Dreazen E, Herman AM, Batukan CEM, Holzgreve W, Tercanli S. Bedside estimation of Down syndrome risk during first-trimester ultrasound screening. Ultrasound Obstet Gynecol 2002; 20: 468-475.
11. Robinson HP, Fleming JEE. A critical evaluation of sonar crown-rump length measurements. Br J Obstet Gynaecol 1975; 82: 702-710.
12. Herman A, Maymon R, Dreazen E, Caspi I, Bukovsky I, Weinraub Z. Nuchal translucency audit: a novel image-scoring method. Ultrasound Obstet Gynecol 1998; 12: 398-403.
13. Herman A, Dreazen E, Samandarov A, Bukovsky Y, Weinraub Z, Maymon R. On-to-on versus on-to-out nuchal translucency measurements. Ultrasound Obstet Gynecol 2000; 15: 126-130.
14. Nicolaides KH, Snijders RJM, Cuckle HS. Correct estimation of parameters for ultrasound nuchal translucency screening. Prenat Diagn 1998; 18: 519-521.
15. Spencer K, Bindra R, Nix ABJ, Heath V, Nicolaides KH. Delta-NT or NT MoM: which is the most appropriate method for calculating accurate patient-specific risks for trisomy 21 in the first trimester? Ultrasound Obstet Gynecol 2003; 22: 142-148.
16. Maymon R, Herman A, Dreazen E, Tovbin Y, Bukovsky Y, Weinraub Z. Can nuchal cord cause transient increased nuchal translucency thickness? Hum Reprod 1999; 14: 556-559.
17. Tercanli S, Miny P, Siebert MS, Hosli I, Surbek DV, Holzgreve W. Fanconi anemia associated with increased nuchal translucency detected by first trimester ultrasound. Ultrasound Obstet Gynecol 2001; 17: 160-162.
18. Ville Y. Nuchal translucency in the first trimester of pregnancy: ten years on and still a pain the neck? Ultrasound Obstet Gynecol 2001; 18: 5-8.
19. Bilardo CM, Pajkrt E, de Graaff IM, Mol BW, Bleker OP. Outcome of fetuses with enlarged nuchal translucency and normal karyotype. Ultrasound Obstet Gynecol 1998; 11: 401-406.
20. Adekunle O, Gopee A, el-Sayed M, Thilaganathan B. Increased first trimester nuchal translucency: pregnancy and infant outcomes after routine screening for Down's syndrome in an unselected antenatal population. Br J Radiol 1999; 72: 457-460.
21. Souka AP, Snijders RJM, Novakov A, Soares W, Nicolaides KH. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks' gestation. Ultrasound Obstet Gynecol 1998; 11: 391-400.
22. Maymon R, Padoa A, Dreazen E, Herman A. Nuchal translucency measurements in consecutive normal pregnancies: is there a predisposition to increased levels? Prenat Diagn 2002; 22: 759-762.
23. Hiippala A, Eronen M, Taipale P, Salonen R, Hiilesmaa V. Fetal nuchal translucency and normal chromosomes: a long-term follow-up study. Ultrasound Obstet Gynecol 2001; 18: 18-22.
24. Senat MV, De Keersmaecker B, Audibert F, Montcharmont G, Frydman R, Ville Y. Pregnancy outcome in fetuses with increased nuchal translucency and normal karyotype. Prenat Diagn 2002; 22: 345-349.
25. Cheng CC, Bahado-Singh RO, Chen SC, Tsai MS. Pregnancy outcomes with increased nuchal translucency after routine Down syndrome screening. Int J Gynaecol Obstet 2004; 84: 5-9.